BuyCancerDrugs.com BuyCancerDrugs.com
BuyCancerDrugs.com BuyCancerDrugs.com
OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer
Search OncologyJournal.org
Browse by Cancer Type or Cancer Drug

Go Back   OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer > Blogs
Connect with Facebook


Old

Fewer Left-Sided Colorectal Tumors Observed After Colonoscopies

Posted 01-25-2010 at 11:56 PM by admin
ScienceDaily (Jan. 2, 2010) — The prevalence of left-sided advanced colorectal neoplasms was lower in participants in a community setting, but not right-sided advanced neoplams, who had received a colonoscopy in the preceding 10 years, according to a new study published online December 30 in the Journal of the National Cancer Institute.

Effectiveness of colonoscopy in preventing colorectal cancer has been studied, but evidence from community settings is sparse, especially with respect...
Administrator
Comments 0 admin is offline
Old

Aggressive Brain Cancer Driven By Two Collaborating Genes, Study

Posted 01-25-2010 at 11:46 PM by admin
Medical News Today
Article Date: 30 Dec 2009 - 2:00 PST

US researchers have discovered two genes that appear to work together as master switches to turn on hundreds of other genes that drive the most aggressive forms of brain cancer: they hope their findings will help develop completely new approaches to treat these incurable tumors.

These are the findings of a study published in the 23 December advanced online issue of the journal Nature, that was led by Dr Antonio...
Administrator
Comments 0 admin is offline
Old

Pfizer Disc. Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer For Futility

Posted 01-25-2010 at 11:27 PM by admin
Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility

Business Wire
December 29, 2009 05:01 PM Eastern Time

Findings to be Incorporated into Ongoing Clinical Trial Program

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today the discontinuation of A4021016 (also known as ADVIGO 1016), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) as first-line treatment in patients...
Administrator
Comments 0 admin is offline


All times are GMT. The time now is 12:24 AM.


Powered by vBulletin® Version 3.8.1
Copyright ©2000 - 2010, Jelsoft Enterprises Ltd.